Atypical signaling defects prevent IL-2 gene expression inIpr/Ipr CD4-CD8-cells
- 1 July 1998
- journal article
- research article
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 5 (4) , 297-304
- https://doi.org/10.1007/bf02255862
Abstract
T cells with CD4-CD8- (double negative, DN) phenotype in MRL-lpr/lpr mouse serve as a model to establish the correlation between the extremely low IL-2 gene expression and the specific signaling inactivation. The extent of non-responsiveness inlpr DN cells was distinctive in several unusual defects. First, the poor IL-2 production inlpr DN cells could not be restored by supplement of signals known to augment IL-2 response in normal T cells. Second, the activations of both mitogen-activated protein (MAP) kinase and c-Jun N-terminal kinase (JNK) were attenuated inlpr DN cells upon direct activation by TPA/A23187. Third, IL-2 mRNA was degraded much faster inlpr DN cells than that in normal T cells. Fourth, of the four major transcriptional elements on IL-2 promoter, only AP-1 and nuclear factor of activated T cells (NFAT)-binding activities were suppressed inlpr DN T cells. Altogether, these results suggest that an extremely low level of IL-2 production inlpr DN T cells was due to both the increased instability of mRNA and the reduced activation of IL-2 gene promoter, the latter defect could be attributed to the inactivation of AP-1 and NF-AT as well as the poor activation of the upstream MAP kinase and JNK.Keywords
This publication has 33 references indexed in Scilit:
- Apoptosis by Death FactorCell, 1997
- Blocked Signal Transduction to the ERK and JNK Protein Kinases in Anergic CD4 + T CellsScience, 1996
- The regulation and function of p21ras during T-cell activation and growthImmunology Today, 1995
- An open study of dehydroepiandrosterone in systemic lupus erythematosusArthritis & Rheumatism, 1994
- The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domainCell, 1993
- The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter.The Journal of Experimental Medicine, 1992
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992
- Lpr and gld: Single Gene Models of Systemic Autoimmunity and Lymphoproliferative DiseaseAnnual Review of Immunology, 1991
- CD2 is involved in regulating cyclic AMP levels in T cellsEuropean Journal of Immunology, 1988
- Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2.The Journal of Experimental Medicine, 1981